North Dakota State Investment Board
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2064039
BISMARCK, ND
Position in ALNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,134,582
-$203,456 QoQ
Shares Held
3,769
-6.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#384
of 784 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026North Dakota State Investment Board holds $18,095,607 across 20 Biotechnology names. ALNY ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,547 | $3,748,821 | |
| 2 | MRNA |
Moderna, Inc.
|
43,152 | $3,021,934 | |
| 3 | INCY |
Incyte Corp
|
16,678 | $1,890,618 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,017 | $1,881,220 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3,769 | $1,134,582 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,334 | $998,951 | |
| 7 | INSM |
INSMED Inc
|
6,226 | $663,816 | |
| 8 | RPRX |
Royalty Pharma plc
|
11,431 | $640,936 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,134,582 | 3,769 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,338,038 | 4,044 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,904,345 | 4,789 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||